Lightens hand pigmentation
To better understand the intersection between the hepatic effects of GLP-1R agonist and ethanol, we compared changes in the hepatic transcriptome by GLP-1R agonist with the changes induced by ethanol alone
10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
Ultimately, improving reproductive health for people with diabetes is a matter of changing conversations to make sure women can access the support and education they need both pre- and post-pregnancy, Meek said
Expert consensus on the application of oral hypoglycemic drugs in patients with cardiovascular disease complicated with diabetes mellitus
However, in that network meta-analysis [7], there was high methodological inconsistency between included studies, which brings into question the validity of indirect comparisons across drug classes
